Your shopping cart is currently empty

NLRP3-IN-42 (compound H28) is a potent inhibitor of NLRP3 with a KD value of 1.15 µM. It effectively reduces the protein expression of cleaved-caspase-1 (p20) induced by LPS and selectively inhibits the release of IL-1β.
| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 10 mg | Inquiry | Inquiry | Inquiry | |
| 50 mg | Inquiry | Inquiry | Inquiry |
| Description | NLRP3-IN-42 (compound H28) is a potent inhibitor of NLRP3 with a KD value of 1.15 µM. It effectively reduces the protein expression of cleaved-caspase-1 (p20) induced by LPS and selectively inhibits the release of IL-1β. |
| Targets&IC50 | NLRP3:1.15 μM (kd) |
| In vitro | NLRP3-IN-42 (compound H28) effectively reduces the expression of cleaved-caspase-1 (p20) induced by LPS in a dose-dependent manner (0-30 µM). Additionally, NLRP3-IN-42 stably binds to the ADP active site of the NACHT domain of NLRP3. |
| In vivo | NLRP3-IN-42 (10 mg/kg; i.p.) selectively inhibits the release of IL-1β by suppressing the NLRP3 inflammasome, without significantly affecting the inflammatory factor TNF-α. |
| Formula | C29H27F3N2O3S2 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
Dissolve 2 mg of the compound in 100 μL DMSO
to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
1) Add 100 μL of the DMSO
stock solution to 400 μL PEG300
and mix thoroughly until the solution becomes clear.
2) Add 50 μL Tween 80 and mix well until fully clarified.
3) Add 450 μL Saline,PBS or ddH2O
and mix thoroughly until a homogeneous solution is obtained.
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.